CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 591 enrolled
Drug / intervention
Observational treatment compliance surveyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00460720
NCT00460720N/ACompleted
CompareCT.gov

Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)

Johnson & Johnson Taiwan Ltd·observational·Posted Apr 16, 2007·Updated Apr 28, 2010

In Brief

An observational study evaluating Observational treatment compliance survey for Attention Deficit Disorder With Hyperactivity. Completed, enrolled 591 participants.

Detailed Summary

The survey is designed to identify non-compliant Attention Deficit Hyperactivity Disorder (ADHD) patients who are currently on Immediate- Released Methylphenidate (IR-MPH) and observe any change in compliance after treating with other drugs intended to treat ADHD for over 3 weeks

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAttention Deficit Disorder With Hyperactivity
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 16, 2007
Study CompletionFeb 1, 2006
TodayJul 2, 2026
Posted 19.2 years ago

Interventions

Observational treatment compliance surveyother

Observational treatment compliance survey